February 1, 2017

Dear Colleagues,

I am pleased to announce that after an extensive national search, we have selected Dr. Vaibhav Saini to serve as Licensing Director for Life Sciences at UConn and UConn Health, effective immediately.

In this role, Vaibhav will be responsible for managing the evaluation, patenting, and licensing of a portfolio of University inventions in the life sciences. This will include providing support to startup companies affiliated with UConn.

Vaibhav earned his PhD in Cellular and Molecular Physiology from the University of Alabama at Birmingham. There he developed methods to couple gold nanoparticles to gene therapeutic adenoviruses targeted to tumors. As a postdoctoral fellow at the National Institutes of Health, he identified markers and small molecule inhibitors of osteosarcoma stem cells. Recently, as an Instructor in Medicine at Massachusetts General Hospital and Harvard Medical School, he demonstrated that vitamin D signaling suppresses lipid pathways in keratinocyte stem cells to prevent alopecia.

Vaibhav also has extensive experience and a keen interest in commercializing life sciences technologies. He has participated in several technology commercialization programs, such as Johns Hopkins University Carey Business School INNoVATETM and a Harvard Innovation and Commercialization course. He interned for a year at Partners HealthCare Innovation in Boston.

Please join me in congratulating Vaibhav on this new appointment and in welcoming him to the University of Connecticut.

Sincerely,

Dr. Gregory Gallo
Director, Technology Transfer
gregory.gallo@uconn.edu